Recurrent Ovarian Cancer
Conditions
Keywords
Recurrent Ovarian Cancer
Brief summary
Clinical trials, with a particular focus on recurrent ovarian cancer, play a crucial role in assessing the safety and efficacy of novel treatments for this condition. These trials serve as essential tools to determine whether new medications outperform traditional therapies, providing substantial evidence to support their widespread adoption. By actively participating in recurrent ovarian cancer observational study serves pivotal role in expanding the boundaries of medical knowledge and advancing the quality of care provided to those enduring the same condition.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old * Able to comprehend the investigational nature of the protocol and provide informed consent * Diagnosis of recurrent ovarian cancer
Exclusion criteria
* No diagnosis of recurrent ovarian cancer confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to participate in a recurrent ovarian cancer clinical trial | 3 months |
| Rate of patients who remain in recurrent ovarian cancer clinical research to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed